Interview with Alex Zhavoronkov,PhD

Church GM . Personal profile: Interview with George Church. Rejuvenation Res, 2013; 16:171–172.

Coles LS . Interview with L. Stephen Coles, M.D, Ph.D. Rejuvenation Res, 2013; 16:250–253.

Sierra F . Interview with Felipe Sierra, Ph.D. Rejuvenation Res, 2013; 16:78–81.

Appleby J . Interview with James Appleby. Rejuvenation Res, 2013; 16:432–434.

Barker RW . Interview with Richard Barker. Rejuvenation Res, 2013; 16:537–539.

Dominko T . Interview with Tanja Dominko, DVM, Ph.D. Rejuvenation Res, 2014; 17:77–79.

de Grey ADNJ . Competing causes of chronic ill health: What do we do and what should we do?. Rejuvenation Res, 2013; 16:1–2.

de Grey ADNJ . The desperate need for a biomedically useful definition of “aging.”. Rejuvenation Res, 2013; 16:89–90.

de Grey ADNJ . Late-onset, preventative, combination treatments: The triple challenge facing the most promising anti-aging research paradigm. Rejuvenation Res, 2013; 16:177–178.

de Grey ADNJ . A divide-and-conquer assault on aging: Mainstream at last. Rejuvenation Res, 2013; 16:257–258.

de Grey ADNJ . Google's Calico: The war on aging has truly begun. Rejuvenation Res, 2013; 16:343–343.

de Grey ADNJ . Selling anti-aging research: The perils of mixed messages. Rejuvenation Res, 2013; 16:443–445.

de Grey AD . The rational imperative to aim high. Rejuvenation Res, 2014; 17:413–414.

de Grey AD . The practicality or otherwise of biomedical rejuvenation therapies: A response to Kyriazis. Rejuvenation Res, 2014; 17:397–400.

de Grey AD . Scientific debate is an opportunity, not a chore: It benefits the establishment, the heretic, and the observer alike. Rejuvenation Res, 2014; 17:323–324.

de Grey AD . Predicting future longevity: At long last, extrapolation is on the way out. Rejuvenation Res, 2014; 17:247–248.

de Grey AD . The real end of ageism. Rejuvenation Res, 2014; 17:95–96.

Appleby J . The geroscience interest group (GSIG): Tracing pathological consequences of fundamental aging processes. Rejuvenation Res, 2013; 16:S13.

Coeurnelle D . Collective consequences of a very long life. The right to life extension could/should be considered a human right. Rejuvenation Res, 2013; 16:S19.

Khaltourina D . Legal problems of registering substances and therapies to cure aging. Rejuvenation Res, 2013; 16:S27–S28.

Kope M . Reimagine aging. Rejuvenation Res, 2013; 16:S29.

Kuhn R . International futures: Impact of decelerated or abolished aging on human demographic change. Rejuvenation Res, 2013; 16:S29–S30.

Pyszczynski T , Greenberg J . Understanding the paradox of opposition to long-term extension of the human lifespan: Fear of death, cultural worldviews, and the illusion of objectivity. Rejuvenation Res, 2013; 16:S36–S37.

Underwood M , Hall W , Bartlett H . What reassurances do the community need regarding life extension? Evidence from studies of community attitudes and an analysis of film portrayals. Rejuvenation Res, 2013; 16:S42.

Litovchenko M , Zhavoronkov A . New economic arguments for accelerating aging research. Rejuvenation Res, 2013; 16:S44.

Micans P . Why orthodox medicine must change—the need for preventative/regenerative medicine. Rejuvenation Res, 2013; 16:S45.

de Magalhães JP . The scientific quest for lasting youth: Prospects for curing aging. Rejuvenation Res, 2014; 17:458–467.

Kyriazis M . The impracticality of biomedical rejuvenation therapies: Translational and pharmacological barriers. Rejuvenation Res, 2014; 17:390–396.

Stambler I . The unexpected outcomes of anti-aging, rejuvenation, and life extension studies: An origin of modern therapies. Rejuvenation Res, 2014; 17:297–305.

Goldsmith TC . Aging theories and the zero-sum game. Rejuvenation Res., 2014; 17:1–2.

Needham SL . Toward priorities for aging research. Rejuvenation Res, 2014; 17:154–156.

de Grey ADNJ , Ames BN , Andersen JK , Bartke A , Campisi J , Heward CB , McCarter RJM , Stock G . Time to talk SENS: Critiquing the immutability of human aging. Annals NY Acad Sci, 2002; 959:452–462.

Zhavoronkov A . The Ageless Generation. How Advances in Biomedicine Will Transform the Global Economy. St. Martin's Press, New York, 2013.

Zhavoronkov A , Litovchenko M . Biomedical progress rates as new parameters for models of economic growth in developed countries. Int J Environ Res Public Health, 2013; 10:5936–5952.

Zhavoronkov A , Cantor CR . From personalized medicine to personalized science: Uniting science and medicine for patient-driven, goal-oriented research. Rejuvenation Res, 2013; 16:414–418.

Shindyapina AV , Mkrtchyan GV , Gneteeva T , Buiucli S , Tancowny B , Kulka M , Aliper A , Zhavoronkov A . Mineralization of the connective tissue: A complex molecular process leading to age-related loss of function. Rejuvenation Res, 2014; 17:116–133.

Blagosklonny MV . Koschei the immortal and anti-aging drugs. Cell Death Dis, 2014; 5:e1552.

Zhavoronkov A , Cantor CR . Methods for structuring scientific knowledge from many areas related to aging research. PloS One, 2011; 6:e22597.